Previous Close | 650.90 |
Open | 660.49 |
Bid | 260.36 x 800 |
Ask | 1,041.44 x 1000 |
Day's Range | 646.94 - 660.49 |
52 Week Range | 585.27 - 805.62 |
Volume | |
Avg. Volume | 3,624 |
Market Cap | 1.17B |
Beta (5Y Monthly) | 0.21 |
PE Ratio (TTM) | 34.49 |
EPS (TTM) | 18.99 |
Earnings Date | Nov 07, 2022 - Nov 11, 2022 |
Forward Dividend & Yield | 7.80 (1.20%) |
Ex-Dividend Date | Jun 14, 2022 |
1y Target Est | N/A |
Subscribe to Yahoo Finance Plus to view Fair Value for ATRI
ALLEN, Texas, Aug. 08, 2022 (GLOBE NEWSWIRE) -- Atrion Corporation (NASDAQ: ATRI) today announced its results for the second quarter ended June 30, 2022. Revenues for the second quarter of 2022 totaled $48.9 million compared to $42.7 million for the same period in 2021. For the quarter ended June 30, 2022, operating income was $11.0 million, up $1.2 million over the comparable 2021 period, and net income was $9.3 million, up $424 thousand over the same period in 2021. Second quarter 2022 diluted
If you're not sure where to start when looking for the next multi-bagger, there are a few key trends you should keep an...
ALLEN, Texas, May 24, 2022 (GLOBE NEWSWIRE) -- Atrion Corporation (NASDAQ: ATRI) today announced that its Board of Directors declared a quarterly dividend of $1.95 per share on its outstanding shares of Common Stock. This dividend will be payable on June 30, 2022 to stockholders of record at the close of business on June 15, 2022. Atrion Corporation develops and manufactures products primarily for medical applications. The Company’s website is www.atrioncorp.com. Contact:Jeffery Strickland Vice